About Approach ES&G Products Patient Resources Investors Careers Contact Partnering LinkedIn Care Where patients, partners, and quality matter For over 75 years, Lannett has been proudly providing high-quality, affordable generic pharmaceutical products to patients who depend on them. LEARN MORE What product are you looking for? Search Patient Support We manufacture over 100 unique pharmaceutical product families for a wide range of therapeutic areas, with many more in development. Our philosophy? Patients first. LEARN MORE Our Approach Many of our patients will never know they are taking one of our medicines. But we know. That’s why we strive for the highest quality standards in our pharmaceutical products. LEARN MORE Careers Our culture combines a legacy of quality with an appetite for innovation. We’re looking for motivated, engaged individuals to help make the medicines that save and enhance lives. LEARN MORE Spotlight August 30, 2021 Lannett Commences Marketing Mycophenolate Mofetil For Oral Suspension “Our Abbreviated New Drug Application (ANDA) for Mycophenolate Mofetil for Oral Suspension received a first-cycle approval from the FDA, which underscores the quality of our filing, as well as our product development team,” said Tim Crew, chief executive officer of Lannett. “Moreover, this approval is a noteworthy accomplishment, given that the product represents a new dosage form for us, powder for oral suspension. Currently, only two other competitors market generic Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL, in the U.S.” Authorized Distributors of Record Copyright © 2021 Lannett Site Map Privacy Policy Product Return Policy Terms and Conditions Contact Us LinkedIn